针对RAD51-BRCA2相互作用的计算设计的aptamers损害同源重组并诱导合成致死性
Giulia Milordini1,2, Elsa Zacco1, Mirco Masi2
1RNA Systems Biology, Istituto Italiano di Tecnologia, Genoa, Via Enrico Melen, 83, Genoa, Italy.
Nature communications
|December 1, 2025
概括
科学家们设计了aptamer来破坏RAD51-BRCA2相互作用,这是一个关键的DNA修复过程. 这种方法通过增强化疗敏感性和诱导合成致死性,对癌症治疗具有前景.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 药物发现 药物发现 药物发现
背景情况:
- RAD51-BRCA2相互作用对同源重组 (HR) DNA修复至关重要,对癌细胞存活至关重要.
- 针对这种相互作用可以使癌细胞对化疗更敏感.
研究的目的:
- 设计一种可以选择性抑制RAD51-BRCA2相互作用的aptamers.
- 为了评估这些体在调节DNA修复和增强癌症治疗中的有效性.
主要方法:
- 在体中,APTAMER的设计针对RAD51.1.
- 在体外验证使用生物层干涉计 (BLI) 和光终身成像显微镜 (FLIM).
- 在胰腺癌细胞和3D球形模型中进行评估.
主要成果:
- 确定了一种高亲和度的阿普坦酶,它在RAD51结合方面与BRCA2竞争.
- 通过破坏RAD51/BRCA2核定位,从而增加DNA损伤,阿普坦酶会损害HR.
- 与olaparib的组合诱导癌细胞的剂量依赖的合成致死性.
结论:
- 在DNA修复途径中基于aptamer的蛋白相互作用的破坏是一种可行的治疗策略.
- 这种方法为基于合成致死性的癌症治疗提供了一个有希望的新途径.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Homologous Recombination
62.4K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
62.4K
Long-patch Base Excision Repair
7.8K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.8K
Restarting Stalled Replication Forks
6.2K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
6.2K
Conservative Site-specific Recombination and Phase Variation
6.6K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.6K


